The Recall Desk
ModerateFDA (Drugs)·D-0421-2025·Announced 2025-05-28

Artridon Topical Analgesic Recalled for Manufacturing Process Deviations

Kenil Healthcare is recalling 9,984 tubes of Artridon topical analgesic (menthol and methyl salicylate) due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects units distributed in Delaware and North Carolina.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The FDA classified this as Class II with no reported illnesses or injuries. The hazard is a manufacturing process deviation (CGMP violation) that presents a potential quality concern but no direct health threat is documented in the source text.

Plain-English summary

Kenil Healthcare Private Limited is recalling Artridon Glucosamine topical analgesic cream, a 5 oz (142g) tube containing menthol 2% and methyl salicylate 15% for arthritis joint pain relief. The recall includes 9,984 tubes with lot SP25A and expiration date 09/30/2026.

The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. This is a voluntary, firm-initiated recall. The product is distributed by Pharmadel LLC in New Castle, Delaware.

The recall affects units distributed in Delaware and North Carolina. Consumers who have purchased this product should stop using it and consult their healthcare provider if they have questions about alternative pain relief options.

The recalled product

Product
ARTRIDON (MENTHOL, METHYL SALICYLATE)
Brand
ARTRIDON
Manufacturer
KENIL HEALTHCARE PRIVATE LIMITED
Hazard
  • cgmp-deviation
  • manufacturing-process-deviation

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot SP25A
  • Exp Date: 09/30/2026

UPCs (1)

  • 810096771513

Distribution

Distributed in 2 states:

  • DE
  • NC